Lepranal Pharmaceuticals Profile
Key Indicators
- Authorised Capital ₹ 0.30 M
- Paid Up Capital ₹ 0.30 M
- Company Age 41 Year, 6 Months
- Last Filing with ROC 31 Mar 2016
- Open Charges ₹ 1.03 M
- Revenue Growth %
- Ebitda
- Net Worth
- Total Assets %
About Lepranal Pharmaceuticals
Lepranal Pharmaceuticals Private Limited (LPPL) is a Private Limited Indian Non-Government Company incorporated in India on 27 July 1983 and has a history of 41 years and six months. Its registered office is in Hyderabad, Telangana, India.
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2016. It's a company limited by shares with an authorized capital of Rs 0.30 M and a paid-up capital of Rs 0.30 M.
The company currently has active open charges totaling ₹1.03 M.
Krishna Narra and Indrani Narra serve as directors at the Company.
Company Details
- Location
Hyderabad, Telangana, India
- Telephone
+91-XXXXXXXXXX
- Email Address
- Website
-
- Social Media -
Corporate Identity Details
- CIN/LLPIN
U24239TG1983PTC004054
- Company No.
004054
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
27 Jul 1983
- Date of AGM
30 Sep 2016
- Date of Balance Sheet
31 Mar 2016
- Listing Status
Unlisted
- ROC Code
Roc Hyderabad
Industry
Who are the key members and board of directors at Lepranal Pharmaceuticals?
Board Members (2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Krishna Narra  | Director | 27-Oct-2003 | Current |
| Indrani Narra | Director | 27-Oct-2003 | Current |
Financial Performance of Lepranal Pharmaceuticals.
Lepranal Pharmaceuticals Private Limited, for the financial year ended 2016, experienced no change in revenue, with a 0% increase. The company also saw a no change in profitability, with a 0% increase in profit. The company's net worth witnessed no change by increase of 0%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue | |||||||
| Revenue from Operations | |||||||
| Total Assets | |||||||
| Profit or Loss | |||||||
| Net Worth | |||||||
| EBITDA |
What is the Ownership and Shareholding Structure of Lepranal Pharmaceuticals?
In 2016, Lepranal Pharmaceuticals had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Ikin Mega Projects Private LimitedIndrani Narra is a mutual person
- Ink Soft Private Limited
Indrani Narra is a mutual person
- Ink Systems India Private Limited
Indrani Narra is a mutual person
- Amaravathi Health City Private Limited
Indrani Narra is a mutual person
- Ink Pharma Private Limited
Indrani Narra is a mutual person
- Kin Pharma Private Limited
Indrani Narra is a mutual person
Charges (Loans)
₹1.03 M
₹0
Charges Breakdown by Lending Institutions
- Andra Pradesh Financial Corporation : 0.08 Cr
- Canara Bank : 0.02 Cr
Latest Charge Details
| Date | Lender | Amount | Status |
|---|---|---|---|
| 14 Jun 1985 | Canara Bank | ₹0.23 M | Open |
| 09 Jan 1985 | Andra Pradesh Financial Corporation | ₹0.80 M | Open |
How Many Employees Work at Lepranal Pharmaceuticals?
Unlock and access historical data on people associated with Lepranal Pharmaceuticals, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Lepranal Pharmaceuticals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Lepranal Pharmaceuticals's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.